Government and Pharma

The discussion dives into the intricate relationship between the US government and Moderna, highlighting decades of funding for biosynthetic pathogens. Insights reveal that the NIH has been deeply involved, even suing Moderna for patent rights, while Moderna countersued Pfizer, claiming their product was superior. The legal entanglements suggest a complex web of agreements and disputes that continue to unfold, with implications that stretch into the future of vaccine development.